Departments of International Health.
Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and.
J Acquir Immune Defic Syndr. 2022 Jul 1;90(S1):S41-S45. doi: 10.1097/QAI.0000000000002964.
HIV-related implementation research holds great promise in achieving the potential of efficacious prevention and treatment tools in reducing the incidence of HIV and improving HIV treatment outcomes among people living with HIV. From the perspectives of HIV-related implementation research training and academia and through consultations with funders and investigators new to implementation research, we identified 5 myths that act as barriers to engagement in implementation research among new investigators. Prevailing myths broadly include (1) one must rigidly apply all aspects of an implementation framework for it to be valid, (2) implementation research limits the type of designs available to researchers, (3) implementation strategies cannot be patient-level or client-level approaches, (4) only studies prioritizing implementation outcomes are "true" implementation research, and (5) if not explicitly labeled implementation research, it may have limited impact on implementation. We offer pragmatic approaches to negotiate these myths with the goal of encouraging dialog, ensuring high-quality research, and fostering a more inclusive and dynamic field of implementation research. Ultimately, the goal of dispelling these myths was to lower the perceived bar to engagement in HIV-related implementation research while still ensuring quality in the methods and measures used.
HIV 相关实施研究在实现有效预防和治疗工具的潜力方面具有很大的前景，这些工具可以降低 HIV 的发病率，并改善 HIV 感染者的治疗效果。从 HIV 相关实施研究培训和学术界的角度出发，并通过与实施研究的新资助者和研究人员进行协商，我们确定了 5 个神话，这些神话是新研究人员参与实施研究的障碍。普遍存在的神话包括：(1) 必须严格应用实施框架的所有方面，它才是有效的；(2) 实施研究限制了研究人员可采用的设计类型；(3) 实施策略不能是针对患者或客户层面的方法；(4) 只有优先考虑实施结果的研究才是“真正的”实施研究；(5) 如果没有明确标记为实施研究，它可能对实施的影响有限。我们提供了一些切实可行的方法来协商这些神话，目的是鼓励对话，确保高质量的研究，并促进更具包容性和活力的实施研究领域。最终，消除这些神话的目的是降低人们对参与 HIV 相关实施研究的认知障碍，同时确保使用的方法和措施的质量。
